Do not rely on protein alone
BPC-157 FDA Approval Status 2026: Clinical Trials Overview BPC-157 FDA Approval Status 2026: Clinical Trials

Contact your GP, trial clinician, or NHS 111 promptly if you experience: Diarrhoea lasting more than 4872 hours without improvement Signs of dehydration , including dark urine, dizziness, dry mouth, or reduced urination Blood in the stool or very dark, tarry stools Severe or persistent abdominal pain, particularly pain radiating to the back, which may rarely indicate pancreatitis a recognised caution across the incretin drug class [5] [6] Severe abdominal pain or cramping accompanied by fever Diarrhoea combined with persistent vomiting , which significantly increases dehydration risk Symptoms that are interfering with daily activities or sleep Seek urgent medical attention (A&E or call 999) if: You are unable to keep any fluids down for more than 24 hours You feel faint, confused, or have a rapid heart rate alongside diarrhoea You develop signs of a severe allergic reaction (rash, swelling, difficulty breathing) If you are unsure whether your symptoms require urgent attention, call NHS 111 for advice at any time

There is also a risk of complications caused by interactions between Reta and other medication a person is currently taking
Continue Fridays
Take your supplement either early in the morning or after exercise, never immediately before physical activity, to avoid stomach discomfort